SCHEMBL7361582

SCHEMBL7361582

CCC(C(=O)O)N1CC(=O)N(Cc2ccc(F)cc2F)c2ccc(CCCCCCN)cc2C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EDNRB P24530 1/20 0.34
EDNRA P25101 1/20 0.34
ALDH1A1 P00352 3/20 0.33
DPP9 Q86TI2 1/20 0.32
AKR1B1 P15121 1/20 0.31
TRPA1 O75762 2/20 0.31
ACHE P22303 4/20 0.31
TDP1 Q9NUW8 1/20 0.31
SDCBP O00560 1/20 0.31
SDC2 P34741 1/20 0.31
ADRA1D P25100 1/20 0.30
ADRA1A P35348 1/20 0.30
ADRA1B P35368 1/20 0.30
PARK7 Q99497 1/20 0.30
ALDH3A1 P30838 1/20 0.30
CLPP Q16740 1/20 0.30
PTGDR2 Q9Y5Y4 1/20 0.30
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9282414 0.87 ACHE (0.33) EDNRBEDNRAACHEADRA1DADRA1A
SCHEMBL7363490 0.87 ITGB3 (0.37) EDNRBEDNRAALDH1A1
SCHEMBL7361482 0.85 SDCBP (0.37) ALDH1A1SDCBPSDC2ALDH3A1PTGDR2
SCHEMBL7361585 0.85 TRPA1 (0.34) EDNRBEDNRAALDH1A1DPP9AKR1B1
SCHEMBL7361583 0.83 PPARG (0.33) EDNRBEDNRAALDH1A1AKR1B1TRPA1
SCHEMBL7359028 0.83 NAAA (0.37) ALDH1A1ACHETDP1
SCHEMBL7357840 0.82 ITGB3 (0.38) ALDH1A1AKR1B1TRPA1ACHEADRA1D
SCHEMBL7362403 0.80 CHRM5 (0.38) EDNRBEDNRAALDH1A1
SCHEMBL7361166 0.79 ITGB3 (0.49)
SCHEMBL7359512 0.78 ITGB3 (0.41) EDNRBEDNRATRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0610334-B1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII B III A RECEPTOR GENENTECH INC (US) 1996-01-24 EP claimed
EP-0610334-A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII b?III a? RECEPTOR. GENENTECH INC (US) 1994-08-17 EP claimed
WO-1993008174-A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPIIbIIIa RECEPTOR GENENTECH, INC. (US) 1993-04-29 WO claimed
US-5663166-A ANTICOAGULANTS OF 1,4-BENZODIAZEPINE-2,5-DIONE AND 2-BENZOAZEPINE-1,4-DIONE DERIVATIVES; PREVENTS FIBRINOGEN BINDING NECESSARY FOR PLATELET AGGREGATION; SIDE EFFECT REDUCTION, E.G. EXCESSIVE BLEEDING GENENTECH, INC. (US) 1997-09-02 US disclosed
US-5565449-A PLATELET AGGREGATION INHIBITORS GENENTECH, INC. (US) 1996-10-15 US disclosed
EP-0610334-B1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII B III A RECEPTOR GENENTECH INC (US) 1996-01-24 EP disclosed
WO-1993008174-A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPIIbIIIa RECEPTOR GENENTECH, INC. (US) 1993-04-29 WO disclosed